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ABSTRACT 
Introduction: Knowing the burden of severe malaria in children and the predictors of 
outcomes for children with severe malaria would help to put up interventions that would 
reduce the risk of poor outcomes and promote survival.  
Aim: The aim of this study was to determine the predictors of outcomes for the children with 
severe malaria admitted at Mchinji district hospital, in Malawi.  
Methods: This was a cross sectional study and 201 randomly sampled files of children 
admitted to Mchinji district hospital with severe malaria in 2013 and 2014 were reviewed. 
Univariate and multivariate logistic regression models were used to predict outcomes for the 
children with severe malaria. 
Results: During the study period there were 2603(N) children admitted with severe malaria. 
A sample of 202 (n) files for children admitted with malaria was randomly selected, and 
201(n) were included in the final analysis. The majority of the children were under the age of 
five years 155 (78.3%), 106 (53.5%) were male, with 147 (73.1%) being self-referrals and 54 
(26.9%) health centre referrals. Fever was the most common presenting complaint, 177 
(88.1%), while 76 (37.8%) had convulsions and 58 (28.9%) had vomiting. All patients were 
treated as per Malawi National Malaria Control Program treatment guidelines. The outcomes 
of the children were either discharged home alive, died, missing (referred to a specialised 
unit, or absconded from hospital).  The case fatality rate was 7.5%. Of the children that died 
11 (73.3%) were children under the age of five years and 9 (60%) were children referred 
from the health centre. Children who were referred from the health centres were more likely 
to die than children who were self referred by guardians from their homes [OR=4.84  
1.63-14.35] 
Conclusion and Recommendations: The study found that being referred from health centre, 
presenting with unconsciousness, long stay in hospital and receiving LA in the course of 
treatment are predictors of outcomes in children admitted with severe malaria. The predictors 
are a combination of patient and health systems factors that influence delay in accessing 
prompt treatment for malaria in general. Therefore, there is need to improve patient care right 
from home and in the hospital with special attention on the patient referral system. Further 
research on community and health system factors to improve the system for caring of 
children with malaria may be required. 
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LIST OF DEFINITIONS 
 
A Severe  Malaria Case : Any child with a positive malaria test, needing hospital 
admission or had any of the following: high fever, convulsions, 
any impairment of consciousness, prostration, respiratory distress 
and abnormal bleeding, severe anaemia, any manifestation of 
shock like severe diarrhoea and vomiting with dehydration. 
 
Self-Referral : Children brought to the hospital by their parents or guardians 
directly from home without passing through another health 
facility. 
 
Health Centre Referral : Children who were brought to hospital after being sent by health 
worker from a primary health facility and may have received 
treatment prior to being sent to the district hospital. 
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CHAPTER ONE: INTRODUCTION 
 
1.1  BACKGROUND INFORMATION  
Malaria remains a major public health problem with 3.2 billion people at risk of the disease 
globally. In 2015, 212 million cases and 429, 000 deaths were attributed to malaria of which 
90% of the cases and 92% of the deaths were registered in Africa (1). Additionally, malaria  
remains a major killer of children (1,2) and  is more common in the rural areas (3).  
 
Malaria is caused by a protozoan parasites called Plasmodium (P. falciparum, P. vivax, P. 
ovale P. Malariae and P. knowlesi) with P. Falciparum being the most common cause of 
severe disease especially in sub-Saharan Africa (1,4) . Malaria parasites are transmitted from 
one infected person to another person by a female Anopheles mosquito bite. Once a person is 
infected, it takes 10 to 15 days after the mosquito bite to develop malaria symptoms (4).  
After a mosquito bite, the infective forms of malaria parasite (the sporozoites) travel to the 
liver to infect the liver cells (hepatocytes) and develop into approximately 30,000 
development stage form of malaria parasites (merozoites) that are released in the 
bloodstream. This form of the parasites invade the red blood cells where they and schizoints 
then merozoite are released when the infected red blood cells rupture. Infected RBCs 
circulate containing ring-stage parasites, and a small proportion of merozoites will develop 
into male and female forms of the parasites (gametocytes) that infect mosquitoes, completing 
the parasite life cycle. The repeated cycles of red blood cell (RBC) invasion, replication and 
merozoite release will results in the exponential growth of the parasite population and lead to 
disease. The removal of infected RBCs by splenic macrophages or the uptake of free 
haemozoin results in the activation of innate immune receptors and storm of immunological 
compunds (cytokines). The circulating cytokines will cause paroxysms and induce the 
expression of adhesion molecules by endothelial cells, which mediate parasite sequestration. 
The sequestration of infected RBCs disrupts blood flow, promotes blood clots, injures cells of 
the blood vessels (endothilial cells) and ruptures vascular walls, leading to the release of 
vascular content and local tissue inflammation. These mechanisms affect different organs and 
contribute to the symptoms of malaria which are not specific to the disease. acute respiratory 
distress, cerebral malaria or placental malaria. Haemolysis of infected and bystander 
(uninfected) RBCs, uptake of altered RBCs by immunological cells of the spleen (splenic 
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macrophages) and cytokine-induced impairment of red blood cells production 
(erythropoiesis) cause anaemia. (5) 
 
symptoms are similar to those of other viral, bacterial and parasitic diseases. They include 
fever, chills, abdominal discomfort, vomiting, loss of appetite, general body pains, difficult 
breathing, convulsions and coma (4). It is reported that children can progressive quickly to 
become very sick and suffer from severe disease if proper treatment is delayed (6).Malaria is 
diagnosed when malaria parasites are detected in a peripheral blood of a patient suspected to 
have malaria through microscopic examination of a blood film or a malaria antigen Rapid 
Diagnostic Test (MRDT) (6). A severe malaria case is when a patient is tested positive of 
malaria and has the following signs and symptoms: coma, recurrent convulsions, respiratory 
distress, shock and severe anaemia. It is a medical emergency that may necessitate intensive 
nursing care and careful clinical management (7). Those given ineffective treatment may end 
up with irreversible damage of vital organs and may die (8). In young children, death due to 
severe malaria exceeds 10% (8). 
 
Malaria is preventable and curable. The World Health Organization (WHO) treatment 
guidelines recommend the use of artesiminin combination therapy and quinine for the 
treatment of malaria. The treatment and management of children with severe malaria require 
a lot of resources and organization, in terms of human resources, financial resources, 
medicines and equipment. This puts a lot of pressure on the health system, the family, and 
community. However, even after recovery, children treated for severe malaria may recover 
with different complications including epilepsy, loss of function of different parts of the body 
including hearing and visual loss (8) requiring further health care management. 
 
Malaria is prevented by avoiding mosquito bites through the use of insecticide treated bed 
nets, applying insect repellents on exposed areas of the body and the use of indoor residual 
sprays (IRS) (10). There are also medicines available for chemoprevention of malaria but 
they are not 100% protective, they need to be combined with personal protective methods.  
An investigation of malaria vaccine is also showing promise in clinical trials and may be 
available in the near future (11).  
 
The Malawi malaria indicator survey of 2014 reported approximately four million suspected 
cases of malaria causing about 40% of all hospital admissions of children less than five years 
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old (12). The Malawi Ministry of Health (MOH) National Malaria Control Program (NMCP) 
is responsible for the control of the disease in the country. The Malaria Strategic Plan of 
2010-2015 aimed to reduce the malaria burden figures of 2010 by 50%, by 2015 (13) The 
unit has scaled up four malaria control strategies and these are: prompt treatment (within 24 
hours of onset) of fevers in children, use of long lasting insecticide treated nets (LLITNs), 
indoor residual spray (IRS) and intermittent preventive treatment (iPT) of malaria to pregnant 
women (13). The Malawian malaria indicator survey of 2014 has since reflected that there is 
an increase in household ownership of ITN from 58% to 70% in 2010  to 2014 respectively 
(13) and 32% of children with fever received recommended anti-malarial medicine 
(Artimesinin Combination Therapy (ACT)) (13). However, the number of children with 
malaria admissions in Malawi has not decreased (14). 
 
Mchinji district is one of the rural districts of Malawi and has a high malaria prevalence rate 
of 65.5% among the population (15) mostly affecting children. About 8% of under-five 
children malaria cases in the district are severe and require hospital treatment. In 2013 alone 
1163 admitted cases of malaria were recorded of which 7.2% resulted in deaths (16).  
 
1.2  PROBLEM STATEMENT  
Children continue to die of malaria in Malawi (1,8,13). The children die when they develop 
severe disease. Children with severe malaria presents with a spectrum of syndromes (17) 
which also indicate the level of complications from the disease. These complications are 
resource demanding throughout the health system and can be influenced by a number of 
factors including socioeconomic status, age, immune status and access to health care. Delay 
to get proper care can occur at health facility level due to the following factor among others, 
incorrect diagnosis and treatment, lack of essential, poor health facility infrastructure and 
equipments to treat severe malaria and its complications. Any factors related to severe 
malaria can be used as a proxy to predict outcomes of those children with the disease 
condition. Knowing and understanding the predictors can help to put intervention that can 
save the children with severe malaria. Management of the children with severe malaria 
therefore, requires the capacity and ability of the health system to detect the severe cases of 
malaria to provide relevant care and ensure survival of the cases (17).  
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1.3  RESEARCH QUESTION 
What are the predictors of outcomes for children with severe malaria admitted to Mchinji 
district hospital? 
 
1.4  JUSTIFICATION  
Identifying the risk factors of adverse outcome for severe malaria in children, would be used 
to predict deaths in children with severe malaria. Knowing predictors of outcomes for 
children with severe malaria would therefore, help to put up interventions that would reduce 
the risk of poor outcomes and promote survival. Therefore, this study was undertaken to 
establish the predictors of outcomes for children with severe malaria. The results will provide 
information for rapid and simple identification of the predictors of outcomes for children with 
severe malaria. This will strengthen best practices in clinical care of the children with severe 
malaria and optimize care to reduce mortality among hospitalized children (18). The 
information obtained from the study will strengthening the information education and 
communication (IEC) materials for malaria control. It will also inform management of severe 
malaria cases in children to reduce or prevent deaths. Hence this study will strengthen the 
strategy of case management and prompt treatment at all levels in the control of malaria in 
the district which is vital in the control of the disease. However these factors have not been 
established at Mchinji district.  
 
1.5 LITERATURE REVIEW  
Mortality due to malaria is persistently high in Africa and malaria trends to have not shown 
any decreasing trends in Malawi (13). This may be because of a number of reasons that 
include individual level factors, limited access to health care services, poor clinical case 
management and increased drug resistance. A number of studies have been done to establish 
clinical factors associated with fatal outcomes of malaria. The aims of most of these studies 
were to improve classification of severe malaria and help clinicians to avoid diagnostic 
delays and deaths by targeting resources to the sickest patients (19). This chapter reviews 
literature on the severe malaria burden, characteristics of children with severe malaria and 
factors associated with death in children with severe malaria. 
 
1.5.1 Incidence and Burden of Malaria 
Malaria has been known for more than 4000 years (20). Currently more than half the 
population of the world is at risk of malaria world wide affecting 95 countries and territories 
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of the world with 90% of the cases occurring in Africa. Thirteen countries in the subSaharan 
Africa account for 76% of malaria cases and 75% death globally (21). Currently the goal in 
all countries with malaria is to reduce levels of transmission remarkably and to reduce the 
numbers of malaria cases and deaths (22). Malaria distribution tends not to be evenly 
distributed even in places where the disease is prevalent (23).  Despite generally increased 
coverage of malaria interventions in the world, studies have shown minimal changes in 
paediatric clinical malaria cases (14).  The disease continues to be a major cause of 
admissions and hospital deaths in children aged 1–5 years, in many endemic areas (24,25). 
 
It is reported that malaria is responsible for 34 percent of all outpatient visits and 40% 0f 
hospital deaths across all ages in Malawi. Malaria continues to be a major public health 
problem in the country and is a major cause of hospital admissions in children under the age 
of five years. More than 95% of the country is endemic to malaria and transimission is 
perennial (26). The disease is responsible  for approximately 6.2 million presumed and 
confirmed cases reported annually from health facilities and by the community  case 
management  program (27). The 2014 malaria indicator Survey (MIS) reported a 33% 
microscopy malaria parisites prevalence in among children under five years country wide 
(28). In Malawi malaria accounts for 15-35% of total hospital deaths (29). 
 
 HIV co-infection has been shown to be associated with  increased incidence of severe 
malaria and other co-morbidity carrying a higher case fatality rate (30). A study done in at 
Queen Elizabeth Central Hospital in Malawi found that 4.6% of children admitted with 
severe malaria to a malaria had a positive blood culture of which the majority had Non-
typhoidal Salmonella bacteria species (NTS) isolates (58%) (31). Non-typhoidal salmonella 
(NTS) infections are a leading cause of sepsis and deaths in African children (32). In general 
1-4% of children diagnosed with malaria are said to be severe enough to require hospital 
admission and parenteral antimalarial treatment (33) but very few  (less than half) of the 
children who develop severe malaria are able to reach the health facility. Those that manage 
to reach the health facility have a case fatality rate of 20% in the hospital (34). Severe malaria 
cases are very difficult and costly to treat as they may need intensive care unit management. 
The actual average provider’s cost for the management of malaria ranges between US$61.08 
for a paediatric malaria inpatient with anaemia and US$74.29 for a case with neurological 
affection (35). The high cost of treatment includes transport costs and hospital cost and many 
poor families who are the most at risk may not afford the treatment resulting in poor access to 
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malaria treatment and deaths of children due to malaria. It is reported that a  child dies of 
malaria somewhere in the world every minute (35).  
 
1.5.2  Characteristics of Children with Severe Malaria   
Children under five are at high risk of severe malaria regardless of the gender of the children 
(36). The risk of clinical malaria in children begins at around 4 months of age with infants 
becoming susceptible to severe disease and death (37). A study done in Nigeria found that 
age less than 11 years, duration of illness of less than 3 days and  presence of fever were 
found to be at  risk of developing severe malaria (38). Those children who live in the rural 
areas where there is poor access to health services are at high risk of developing severe 
malaria because of delayed  and wrong  treatment they receive (39,40). Studies done in 
Kenya and Togo demonstrated that 80% of the children with febrile illnesses were given 
antimalarial treatment at home which may be wrong antimalarials and ineffective treatment 
for the diseases (41,42,43). This result in children developing severe malaria and present to 
the health facility very sick following failure of treatment, also requiring referral to high 
levels of health care as primary health facility will fail to take care of the severely sick 
children. However, even after referral to high level facility, it is not uncommon that children 
with severe malaria are taken care of in basic facilities that do not have the required resources 
to manage the complications of severe malaria (44). In rural health settings where malaria is 
more prevalent, the health facilities mostly have inadequate clinicians and nurses, inadequate 
essential medicines, inadequate infrastructure and equipments to handle malaria cases 
especially severe cases with complications. 
 
1.5.3  Clinical Features of Children with Severe Malaria 
Studies done in Africa have shown that children with severe malaria presents with high fever, 
prostration, impaired conscious level, convulsions, anemia, poor nutrition and underlying 
chronic conditions (18). The  Clinical presentation of the children with severe malaria and 
how they are managed determine the case fatality and survival rates for the children (45). The 
clinical presentation of children with malaria depend on the characteristics of the population, 
health seeking behavior and epidemiology of the disease (46). Studies have shown regional 
differences in proportions of clinical features and outcomes of children with severe malaria 
presenting to hospital (47). The clinical features of the disease are not specific for severe 
malaria. They can also be features of other diseases like bacterial, viral and parasitic 
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infection. Other diseases that can present like malaria include meningitis, sepsis, pneumonia, 
ear infections and gastrointestinal worm infestations (48). 
 
1.5.4 Treatment and management of Severe malaria 
Severe malaria is a critical condition and requires urgent treatment and management. It is 
treated according to WHO guidelines (See Appendix 6) with parenteral quinine, artesunate 
and any other artemisinin derivatives. In Malawi quinine and artesunate are used for the 
treatment of severe malaria. While the aim of treatment is to eradicate the parasites in the 
body, severe malaria treatment includes treatment of the complications of the disease. These 
may include treatment of dehydration, hypoglycaemia, convulsions, coma, anaemia, renal 
insufficiency and bleeding disorders associated with severe malaria (48).  
 
1.5.5  Outcomes of Children with Severe Malaria 
Severe malaria is an advanced staged of the disease and presents a medical emergency which 
require early intervention to prevent further complications and death (49). Otherwise it 
represents the end stage of improperly treated uncomplicated malaria (50). However, with 
proper treatment and clinical care most of the children with severe malaria are discharged 
from hospital alive.  Those who survive severe malaria may remain with other complications 
especially in cerebral malaria. It is reported that approximately 10% of the children who 
survive cerebral malaria have neurological sequelae and may develop cognitive and motor 
functions deficit (51). Children with severe malaria may die if left untreated or when they 
have irreversible multiple organ failures. This may occur even with treatment. A study done 
in Tanzania found that children with multiple signs and symptoms of severe malaria on 
admission have higher risks of dying in hospital. (52). Another study in India demonstrated 
89% survival rate and 11% case fatality rate of the children with malaria (53). Cerebral 
malaria, caused by P falciparum, has a mortality rate of 25%, even with the best treatment 
(48). Those that cannot be treated at lower health care facility need to be referred to high 
level of care like tertiary hospitals. Others may also abscond from hospital.  
  
1.5.6 Factors Associated with Outcomes of Children with Severe Malaria 
Many recent studies have identified factors associated with death in patients with severe 
malaria. These factors include coma, convulsions, respiratory distress hypoglycemia, retinal 
changes, acidosis and the presence of malarial pigment in peripheral blood neutrophils (54). 
In Mozambique, Bassat and colleagues found that malaria deaths depended on the presenting 
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characteristics. Their study showed that out of all the children dying with malaria, 55.0% 
presented with prostration, 41.1% with respiratory distress and 17.3% with severe anaemia 
(55). A study done in Malawi by Kazembe and colleagues found that age, referral status, 
distance from hospital and length of hospital stay for the admitted malaria cases were 
associated with unfavourable outcomes of severe malaria (46). Children receiving severe 
malaria treatment have a typical case fatality rate of 10-20% (17). 
 
Children presenting at the hospital with severe malaria hold a lot of information required for 
the development and implementation of priority public health interventions and also guide 
national policies and treatment protocols for children with severe malaria (47). Analyzing 
data collected on admission of children with severe malaria would provide indicators of the 
predictors of outcomes in children with severe malaria. Hence the need for this study to 
generate information that would guide policy and best practices in clinical management of 
children with severe malaria being admitted to Mchinji district hospital and reduce deaths. 
 
1.6 AIM OF THE STUDY 
The aim of the study was to determine the factors associated with outcomes of children with 
severe malaria admitted at Mchinji district hospital, in Malawi.  
 
1.6.1 Specific Objectives 
i. To determine the proportion of children with severe malaria admitted at Mchinji district 
hospital in 2013 and 2014. 
 
ii. To determine the outcomes of children admitted at Mchinji district hospital with severe 
malaria. 
   
iii. To determine the predictors of outcomes of children with severe malaria admitted at 
Mchinji district hospital. 
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CHAPTER TWO: METHODS AND MATERIALS 
 
2.1 INTRODUCTION  
This chapter describes the study design, study setting, study population, study case selection, 
sample size, data collection, study variables and data analysis. 
 
2.2  STUDY DESIGN  
This was a cross sectional study of malaria cases among children aged between 4 months and 
14 years admitted to Mchinji district hospital, in Malawi in 2013 and 2014. Hospital case 
files for malaria cases admitted between 2013 and 2014 were reviewed. 
 
2.3  STUDY SETTING 
The study was conducted at Mchinji district hospital in Malawi. The hospital serves as a 
referral hospital for 12 health centres and two community hospitals in the district. Mchinji 
district hospital also serves people from Mozambique and Zambia as the district borders with 
these two countries. The hospital is a 200 bed hospital of which 25 are paediatric beds. It has 
laboratory facility, X-ray equipment and an operating theatre for surgical cases but does not 
have an intensive care unit. All malaria cases that require admission are referred to this 
hospital for in-patient care and are considered severe malaria cases. The study utilised data 
collected and recorded in the patients hospital files. 
 
2.4  STUDY POPULATION AND CASE SELECTION 
The study population was all children aged between 4 months and 14 years admitted to 
Mchinji district hospital with severe malaria. A severe  malaria case was any child with a 
positive malaria test needing hospital malaria treatment and had any of the following: high 
fever, convulsions, any impairment of consciousness, prostration, respiratory distress and 
abnormal bleeding, any manifestation of shock like severe diarrhoea and vomiting with 
dehydration (17). There were 2603 children admitted with confirmed diagnosis of malaria 
and 202 children were sampled. The simple systematic random sampling method was used 
where all the malaria cases were numbered 1 to 2603.  
 
Sampling included children with severe malaria and those that had malaria and other 
conditions, including malnutrition, chronic diseases like diabetes, sickle cell anaemia, sepsis, 
meningitis, HIV disease, congenital cardiac diseases, trauma etc.  
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2.4.1  Exclusion Criteria 
The study excluded the following patients: 
1. Those treated for malaria but with unconfirmed malaria diagnosis   
2. Those with missing files and insufficient information,  
 
2.4.2  Sample Size 
Epi-info was used to calculate the sample size of 133 from a population size (N) of 2603 
children with severe malaria admitted to the hospital in two years, using a precision of plus or 
minus 5% for 10% prevalence of severe malaria cases.  Below is the equation used for 
calculating the sample size as shown in the Table 2.1. 
 
Sample size n = [DEFF*Np(1-p)]/ [(d2/Z21-α/2*(N-1)+p*(1-p)]  
 
Table 2.1: Calculated Sample Sizes (n) for Various Precision Levels at 95% CI 
Confidence Level % 
Confidence 
limit 
Sample Size (n) 
1 9-11 1607 
2 8-12 672 
3 7-13 341 
4 6-14 202 
5 5-15 133 
  
A sample size of 133 was calculated at the confidence interval of 95% as commonly used. 
However, the sample was increased to 202 to increase the power and precision of the study to 
estimate the indicators of the study while taking into consideration of the availability of the 
resources.  
 
2.5   DATA COLLECTION 
The data were collected by the investigator using hospital records review method at Mchinji 
district hospital. The malaria patient files were pulled out and data was extracted from them 
using a data extraction tool (see Appendix 3). These files contained demographic and clinical 
records of the patients which include name, age, residential place, gender, history of illness, 
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diagnosis, treatment given, date of admission, date of discharge and the outcome of 
treatment. The files were coded to maintain confidentiality. A pilot study was done on twenty 
randomly sampled patients’ hospital ward files to explore and see data available in the files 
and the ease of further data extraction. However, data were not consistently recorded in the 
files and there was other missing data, especially residential and sociodemographic data for 
the guardians. 
 
2.6  STUDY VARIABLES 
2.6.1  Outcome Variables 
The main outcome variables in the study were discharged home alive, died and unknown. 
Unknown outcome was when the child was referred to other specialized unit or where 
outcome was missing or absconded. 
 
2.6.2  Exposure Variables 
The exposure variables included demographic variables, Health system variables and clinical 
variables. These data were collected on clinical assessment at the hospital and included 
history of the malaria symptoms like fever, convulsions, unconsciousness, vomiting, 
diarrhoea, not eating, not able to sit, abnormal bleeding, etc. Vital signs including 
temperature, respiratory rate, pulse rate, blood pressure and blood glucose level were mostly 
completely missing. The diagnoses like epilepsy, malnutrition, diabetes, chronic cardiac 
diseases, HIV disease and childhood tumours were looked for as a sign of chronic diseases, 
however, these data were also not available. The data variables are shown in table 2.2 below. 
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Table 2.2: List of Data Variables Used 
Data Variable 
Description  of  
Data Variable 
Analysis Done 
Gender Categorical Frequencies and proportions calculated 
Age Categorical Frequencies and proportions calculated 
Referral Status Categorical 
Frequencies, proportions calculated and 
inferential statistics 
Day of Admission Categorical 
Frequencies, proportions and inferential 
statistics 
Signs and Symptoms Categorical 
Frequencies, proportions and inferential 
statistics 
Treatment Given Categorical 
Frequencies, proportions and inferential 
statistics 
Duration of Hospital Stay Continuous 
Frequencies, proportions and inferential 
statistics 
Outcome (Alive, dead, 
absconded, referred) 
Categorical 
Frequencies and proportions calculated 
Frequencies and inferential statistics 
 
2.7   DATA MANAGEMENT  
Data was collected using the data extraction tool (Appendix2) and verified to correct errors 
before entering the data into the Microsoft Excel program and cleaned for any errors. The 
data were then imported from the Excel into STATA Version 13 for analysis. 
 
2.8   DATA ANALYSIS  
Data analysis included calculation of frequencies of children with severe malaria by age, 
gender, referral status, presenting signs and symptoms, treatment given, and according to the 
outcomes of the cases as shown in the Table 2.3 below. 
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Table 2.3: Specific Objectives with Data Analysis Plan 
Specific Objectives Analysis Plan 
To determine the proportion of children with severe 
malaria admitted to Mchinji district hospital and their 
sociodemographic characteristics. 
Descriptive statistics (frequencies 
and percentages) 
To determine the outcomes of children with severe 
malaria admitted to Mchinji district hospital.   
Descriptive statistics (frequencies 
and percentages) 
To determine the predictors of outcomes in children 
with severe malaria admitted to Mchinji district 
hospital 
Inferential statistics (univariate 
and multivariate logistic 
regression using odds ratio and 
95% confidence intervals) 
 
2.8.1  Descriptive Statistics 
Mean with standard deviation was calculated for continuous variables on assumption of  
normal distribution of the sample. Proportions were calculated for categorical variables like 
gender, malaria cases and the clinical syndromes of severe malaria. These were then 
presented as tables of percentages and frequencies. 
 
2.8.2  Inferential Statistics 
Difference in proportions for deaths due to malaria and outcomes were calculated with 95% 
Confidence Interval using Fisher’s exact tests. Odds ratio and 95% confidence interval to 
identify factors associated with the outcomes of severe malaria were calculated using 
univariate and multivariate logistic regression. Statistically significant factors in univariate 
analysis were included in Multivariate logistic models to come up with the predictors of 
outcome for children with severe malaria.  
 
2.9   ETHICAL CONSIDERATIONS 
Ethical approval to conduct the study was obtained from Ethics committee of the University 
of Witwatersrand clearance certificate number M150637 and approval from Mchinji district 
health officer (DHO). Individual cases were given identification codes and data were kept 
confidential and accessed only by the principal investigator.  
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CHAPTER THREE: RESULTS 
 
3.1 INTRODUCTION 
This chapter presents the results of the study. It describes the sample studied and provides the 
flow of selected sample and malaria admissions, characteristics and clinical features, 
outcomes of children with severe malaria admitted between the 2013 and 2014 at the Mchinji 
district in Malawi. The chapter goes further to examine the factors associated with outcomes 
in children with severe malaria at Mchinji district hospital. 
 
3.2  ADMISSIONS OF CHILDREN WITH SEVERE MALARIA 
Details of the study population are summarised in Figure 3.1. Briefly, a total of 11,469 
children were admitted at the hospital between 2013 and 2014. Of these 2603 (22.7%) were 
confirmed as severe malaria cases. Out of the 2603 children with confirmed severe malaria, 
the study randomly sampled 202 cases, however, data was analysed for 201 of the 202 
sampled children because one of the children was excluded due to the extent of missing data. 
Socioeconomic data was missing in the files and was not included in the analysis.  A total of 
573 children admitted died of which 22.9% (131) were malaria related deaths.  
 
Of the 201 cases analysed, 186 (92.5%) children were discharged alive, 15 (7.5%) children 
died. The final outcomes of 12 (6%) children were unknown (7 children were referred to 
other specialized centres and 5 absconded from hospital) see Figure 3.1. 
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Figure 3.1:  Flow Chart of Enrolled Participants 
 
 
 
 
 
 
TOTAL CHILDREN 
ADMISSIONS 
11469 
Total Non-Malaria 
admissions 
8866 (77.3%) 
TOTAL MALARIA 
ADMISSIONS 
2603 (22.7%) 
 
[2472(95%)  
Discharged Alive 
 
131(5%) Died] 
 
Total sampled 
201 (7.7% of SM cases) 
2013 
Admissions 
2958 
2014 
Admissions 
8511 
Discharged 
alive 
174 (86.6%) 
 
Referred to 
Specialized 
units 
7 (3.5%) 
 
Absconded 
from Hospital 
5 (2.5%) 
 
Died 
15 (7.5%) 
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3.3  CHARACTERISTICS OF CHILDREN WITH SEVERE MALARIA 
ADMITTED TO MCHINJI DISTRICT HOSPITAL  
 
3.3.1  Demographics of Children with Severe Malaria  
The majority of the cases were males (53.5%) and those under the age of five years (78%). 
The sample had a mean age of 43.1 (CI:38.5-47.7) months with minimum age being 4 months 
and maximum age 144 months. The age for 4 children was missing. The mean weight of the 
children was 13.2 (CI:12.3-14.1)  Kg with minimum being 5.7 Kgs and maximum 35 Kgs.  
 
3.3.2  Clinical Presentation of Children with Severe Malaria  
Children with severe malaria during the period under study presented with a wide range of 
clinical features. The majority 177 (88.1%) presented with fever followed by convulsions 76 
(37.8%), vomiting 55 (27.4%) and unconsciousness 6 (3.0%). There were very few cases that 
presented with spontaneous bleeding (nose bleeding, bloody diarrhoea or urine) 9(4.5%), 
dehydration 8 (4.0%), jaundice 6 (3.0%) and splenomegaly 3 (1.5%). Data on vital signs 
especially respiratory rate, blood pressure, haemoglobin concentration (Hb) and history and 
signs of chronic diseases were mostly missing and were not included in the analysis.  
 
3.3.3  Admission and Treatment of Children with Severe Malaria 
The majority of the children, 147 (73.1%) were self-referrals straight from home by their 
guardians while 54 (26.9%) were referred through health facilities in the district. Those 
referred through health facilities came from 11 of the 13 health centres in the district and had 
received pre-referral treatment prior to admission at the district hospital.  
 
Out of the sampled cases, 53 (26.4%) of the children were admitted over the weekend 
(Saturday and Sunday) and 148 (73.6%) were admitted during the working week days 
(Monday to Friday). Malaria was confirmed by malaria rapid diagnostic test (MRDT) in 
87.1% of cases while 14.4 % were confirmed by microscopy. All the children were treated as 
per Malawi national malaria treatment guidelines which include quinine, Lumefantrine 
Artemether (LA) combination and paracetamol. However, 51 (25.4%) received malaria 
treatment only and 150 (74.6%) of the children were given malaria treatment plus other 
treatments mainly antibiotics implying covering them for bacterial infections and other 
conditions. Forty (19.9%) of the 201 children received blood transfusion. 
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Figure 3.2: Map of Mchinji District Showing Health Facilities  
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3.3.4  Duration of Hospital Stay for Children with Severe Malaria  
The duration of stay in the hospital varied from 1 day to 14 days, with mean duration of 3.8 
days (95% CI 3.6-4.1 days). Almost half of the children 102 (50.8%) stayed in the hospital 
for a period of 1 to 3 days while 91 (45.3%) stayed for 4-7 days and 8 (3.9%) stayed for more 
than a week in the hospital. However, there was no difference in duration of stay between  
male 3.9 (95% CI:3.5-4.3) days and female 3.8 (95% CI:3.5-4.2) days with a p-value of 0.80. 
Data for chronic diseases and malnutrition were missing. See characteristics of Children with 
severe malaria admitted to Mchinji   district hospital in the Table 3.1 below. 
 
Table 3.1: Characteristics of Children with Severe Malaria  
Characteristics Characteristic  
Number  
(n/N) 
Proportion  
(%) 
Gender 
Males 106/198 53.5 
Females 92 46.5 
Age Group 
< 5 years old (3-60 months) 155/198 78.3 
>5 years old (61-144 months) 43 21.7 
Referral Status 
Health Centre Referral 54 /201 26.9 
Self-referral 147/201 73.1 
   
Presenting Symptoms 
Fever 177 88.1 
Convulsion 76 37.8% 
Unconsciousness 6 3.0 
Vomiting 58 28.9 
Diarrhoea, 32/201 21 10.4 
Difficult breathing 33 16.4 
Treatment Given 
Standard Malaria Treatment 
(SMRx) 
51 25.4 
SMRx plus other Treatments 150 74.6 
Transfused with blood  40 20.3 
Duration of Hospital Stay  
1-3 days 102 50.8 
4-7 days 91 45.3 
8-14 days 8 3.9 
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3.4   OUTCOMES OF CHILDREN WITH SEVERE MALARIA 
The outcomes of the children with severe malaria are shown in Table 3.2. In this study 86.6% 
of the children were discharged alive, 7.5% died, 3.5% were further referred to tertiary 
hospital and 2.5% absconded from hospital. Out of the 15 children that died, 6 (40%) were 
females and 9 (60%) were males of which 11 of those that died were children under the age 
of five and 4 were over the age of five. Out of the children that were referred from health 
centres 9 (16.7%) died and 6 (4.1%) of the self-referred patients died. 
 
Table 3.2: Outcomes of Children with Severe Malaria 
Characteristic (N) 
Outcome 
P-Value 
Alive Died Referr Abs 
Female (92) 81 (88.0) 6 (6.5) 4 (4.4) 1 (1.0) P=0.002 
Male (106) 91 (85.8) 9 (8.9) 3 (2.9) 3 (2.9)  
Age group 
<5 (155) 
>5 (43) 
 
140(90.3) 
32 (74.4) 
 
11 (7.1) 
4 (9.3) 
 
1 (0.6) 
6 (14.0) 
 
3 (1.9) 
1 (2.3) 
 
P=0.001 
Self Referral (147) 132 (89.8) 6 (4.1) 4 (2.8) 5 (3.4) P=0.012 
HC Referral (54) 42 (77.7) 9 (16.7) 3 (9.3) 0 (0.0) P=0.007 
SMA  (Hb  =/<5.0 (29) 27 (93.1) 2 (6.9) 0 (0.) 0 (0.) 0.469 
Std Rx (51) 49 (96.1) 2 (3.9) 0 (0.0) 1 (2.0) 0.417 
Plus Other Rx (150) 137 (91.3) 13 (8.7) 0 (0.0) 0 (0.0) 0.364 
Transfused (40) 39 (97.5) 1 (2.5) 0 (0.0) 0 (0.0) 0.312 
Hospital days       
<4 days  (102) 86 (84.3) 11 (10.8) 3 (2.9) 2 (2.0) P=0.141 
4 – 7 days (91) 82 (90.1) 2 (2.2) 4 (4.4) 3 (3.3)  
>7 days (8) 6 (75.0) 2 (25.0) 0 (0.0) 0 (0.0)  
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3.5  FACTORS ASSOCIATED WITH OUTCOMES IN CHILDREN WITH 
SEVERE MALARIA AT MCHINJI DISTRICT HOSPITAL 
 
The results of the analysis are shown in Table 3.3. In the univariate analysis, being referred 
from health centre, unconsciousness and duration of stay in hospital were associated with 
either dead or alive in children admitted with severe malaria. Receiving LA and paracetamol 
were associated with less chances of mortality. However, Gender, age, fever, convulsions, 
vomiting, diarrhoea, feeding problem, cough, difficult breathing, temperature, dehydration, 
blood transfusion and treatment options were not statistically significant. 
 
In univarieate analysis, children referred from health centres were more than four times likely 
to die when compared to the self-referral group, OR: 4.84 (CI:1.63-14.35, p=0.004). Children 
who were reported unconscious were sixteen times likely to die than those who were not, 
with the OR 16.00 (CI 1.22-210.59, p=0.035) despite that the observed numbers were small 
and the wide confidence level. Children who stayed in hospital for 8 to 14 days were 2.76 
times more susceptible to die when compared to those who stay for 1 to 3 days only, though 
not statistically significant (CI:0.47-15.37, p=0.247) as the numbers analysed are small. 
Children that stayed in hospital for 4 to 7 days were less likely to die when compared to 
children that stayed for a shorter duration of stay in hospital of 1 to 3 days. From both the 
univariable  and multivariable models the reported OR suggest that the odds of dying is lower for 4-7 
days compared to 1-3 days stay in hospital and higher for 8 days plus compared to 1-3 days. This 
suggests a U-shape of odds on risk of death, which may needs futher exploration and explaination. 
In multivariate analysis children referred from health centres were eleven times more likely 
(OR:11.07, CI:1.16-105.79, p=0.037) to die than those who were self-referrals despite the 
small numbers analysed resulting in the wide confidence levels. Lumefantrine/Artemether 
(LA) administration maintained its protection to the children (OR:0.01, CI:0.01-0.08, 
p<0.001) in multivariate analysis. 
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Table 3.3: Factors Associated with Outcomes for Children with Severe Malaria  
 Characteristic 
uOR (95% 
CI) 
p-
Value 
aOR (95% 
CI) 
p-
Value 
Gender 
Female 1  1  
Male 
1.40  
(0.48-4.10) 
0.537 
0.68  
(0.11-4.41) 
0.687 
Age Interval 
3-60 months 1  1  
61-144 months 
1.33  
(0.40-4.41) 
0.638 
1.02  
(0.24-4.27) 
0.975 
Referral Status 
Self-Referral 1  1  
HC referral 
4.84  
(1.63-14.35) 
0.004 
11.07 
(1.16-105.79) 
0.037 
Hospital Stay 
1-3 days 1  1  
4-7 days 
0.19  
(0.04-0.86) 
0.032 
0.31  
(0.04-2.38) 
0.263 
8-14 days 
2.76  
(0.49-15.37) 
0.247 
10.22 
(0.85-123.33) 
0.067 
Treatment  
Options 
Std malaria 
treatment 
1    
other treatment 
2.32  
(0.51-10.67) 
0.278   
            *uOR= Unadjusted Odds Ratio.  aOR= Adjusted Odds Ratio 
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CHAPTER FOUR: Discussion 
This chapter gives overview of the study findings. A detailed outline of the outcomes and the 
predictors of outcomes is then provided and explained. The outcomes in the study were: 
discharged home alive, death and unknown. The unknown outcomes were of those that were 
further referred to tertiary hospital and those children that absconded from the district 
hospital. The following factors were found to predict outcomes for the children with severe 
malaria: referral from health centre, duration of hospital stay, state of unconsciousness and 
being treated with LA. This chapter also goes on to discuss the limitations, conclusion and 
recommendations of the study. 
4.1 OUTCOMES FOR CHILDREN WITH SEVERE MALARIA. 
4.1.1 Discharged Alive 
In this study the majority of the children (86.6%) were discharged alive and almost all of 
them stayed in the hospital for less than a week. This is similar to a study done in India that 
found 89% of the children with severe malaria being discharge alive after severe malaria 
treatment (53). This is not surprising because malaria is curable with prompt and proper 
antimalarial treatment and management of complications. All the children were treated 
according to the National Malaria Control Program treatment guidelines with almost three 
quarters receiving antibiotics on top of the malaria treatment. In Malawi severe malaria is 
treated with parenteral quinine and artesunate followed by oral LA for three days as soon as 
the patient is able to swallow and may be discharged.  This is consistent with studies done to 
compare quinine and artesunate done in Africa and Asia (56). The majority of severe malaria 
patients treated with quinine or Artesunate are usually discharged from hospital after 4 to 8 
days of treatment (56). The WHO and National Malaria treatment guidelines recommends 
that children with severe malaria should also be treated with antibiotics to cover for other 
infections associated with severe malaria when suspected. Studies have shown that severe 
malaria in children is associated with invasive bacterial infections and it is recommended to 
give antibiotic together with antimalaria treatment (57). This implies the majority of children 
may be coming to hospital with manageable complication and that the malaria treatment 
being given to the children may be effective enough to cure malaria and the recommended 
treatment protocols need to be encouraged and adhered to while monitoring for resistance.  
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4.1.2 Mortality 
The study found that 7.5% of the children with severe malaria died in hospital while on 
treatment and the majority (73.3%) of those that died were children under the age of five 
years. This finding may not be surprising again because literature has recorded that in areas 
of endemic malaria, like Mchinji in Malawi, children under the age of five years are the most 
susceptible to severe malaria and death.  The condition represents the severity of the disease 
which develops when treatment is delayed.  Severe malaria patients die when they are not 
treated and when the extent of vital organ dysfunction is high. Children with severe malaria 
have high chances of dying within the first 2 days of admission regardless of treatment (56).  
In this study the majority (73.3%) of the children that died stayed in hospital for less than 4 
days which is correlates with others studies. It may therefore, suggests delay in receiving 
effective treatment for uncomplicated malaria in the children and care may have been sort 
late. It has been reported in some studies that medical care is sort when the cases are very 
severe and near fatal (54,55). The case fatality rate in this study is consistent with previous 
studies of children with severe malaria done in Gabon, Kenya and Yemen that have reported 
case fatality rates varying from 1- 25% (58).  
 
In this study it was further found that more than half (60%) of the children that died were 
referral cases from the health centres and had a case fatality rate of 16.7% compared to 4.1% 
for the self referrals. This suggests that children being referred form from the health centres 
were more sick with more complications than those that were not referred. Malaria in 
children progresses quickly to severe disease increasing the susceptibility for the children to 
die. Further delay to access treatment increases the risk. It is therefore essential to ensure 
quick interventions in children with severe malaria and that health facilities are well equipped 
or resourced to enable them to take care of children with severe malaria  
 
4.1.3 Further referral and absconding 
In our study some children (3.5%) were further referred to tertiary hospital probably for 
further supportive treatments like ventilation, dialysis and heamodynamic support or surgical 
interventions which require intensive care unit services not available in district hospitals in 
Malawi. However, the reasons for referral were missing. and the final outcomes of those 
referred to tertiary hospital were unknown. This suggests poor communication between 
Mchinji district hospital and the tertiary hospital where the children were referred to resulting 
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in no follow up and feedback between hospitals. A study done in Iran found that poor 
linkages in a patient referral system in three tier health care system in most places result in 
loss of information on referred patients (59). It was further found that 2% of the children 
absconded from hospital. While it is difficult to explain the reasons for absconding, it can be 
speculated that it is because of poor understanding of the children’s condition by the 
guardians to tolerate treatment and hospital environment due to low literacy levels and 
cultural beliefs. Also guardians may not have been satisfied with quality of care and 
absconded to try other services elsewhere like traditional medicines. However, there is very 
little or no accurate evidence available in literature on patients who abscond from hospital 
(60)  
4.2 PREDICTORS OF OUTCOMES FOR CHILDREN WITH SEVERE 
MALARIA 
4.2.1 Referral from Primary Health Centre 
In this study being referred from primary health centre was found to be an independent 
predictor of outcomes for children admitted with severe malaria. It was found that 60% of the 
children that died were referral cases from the health centres and had a case fatality rate of 
16.7% compared to 4.1% for the self referrals. Children referred from health centres were 
more than eleven times likely to die in the hospital when compared to the self referral group. 
This is similar to findings by a study in Zomba, Malawi (46). Children being referred from 
the health centre to the district hospital may have been experiencing delays emerging from 
the health centres and community.  These issues may be lack of resources and inefficiencies 
at the facilities due to lack of human resources (Clinicians and nurses), lack of essential 
medicines and equipments, and lack of availability of ambulances for transporting patients to 
the district hospital causing delay to prompt and effective treatment for children with severe 
malaria. Other studies have shown that children may also be presented at the health centre in 
already critically sick condition due to late presentation from home as a result of poor health 
seeking behaviour, cultural beliefs (61,62), poor access to health care, high costs of care 
including transport costs (63). Delays to treat children with severe malaria allows disease 
progression to further severe complications and deaths (64,65,66,67,68). Barriers to health 
care services promote malaria progression of diseases to very severe conditions increasing 
chances of death in children with severe malaria. Fever in malaria endemic places has been 
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used as a proxy for diagnosis of malaria presumptively (69). This means there is need to 
promote prompt treatment of fevers in children in Mchinji district.  
Mchinji is a rural district in Malawi and has an average health centre catchment population of 
33,137 with an average distance of 34Km from the primary health facilities to the district 
hospital with very poor road network and infrastructure (70). Rural health centres have 
challenges to deliver quality health services. It has been reported that often rural health 
facilities are challenged with inadequate human resources, stock-out of essential and effective 
drugs, lack of essential equipment and lack of quick access to ambulance support when 
needed (58,68,71,72,73,74,75). Such factors compound the problem of poor quality health 
care service delivery especially to those that are critically ill like children with severe 
malaria. Therefore, children with severe malaria and referred from the health centres may 
have severe complications due to delays in the health system and have high risk of dying in 
the district hospital. There is need to look into health systems strengthening for malaria 
control interventions both at community and health facility levels to prevent development of 
severe malaria and deaths in children. The Integrated management of childhood illnesses 
(IMCI) strategies in the district needs to be improved and strengthened to prevent childhood 
illnesses and deaths especially due to malaria. The IMCI promotes early identification of 
children with fever..... 
4.2.2 Duration of hospital stay 
The results of the study showed that the occurrence of deaths of children may take a U-shape, 
with more deaths occurring in the first days and longer days in hospital. Out of the fifteen 
children that died, eleven died within three days of hospital stay. Those children that stayed 
in the hospital for more than seven days were about three times more likely to die in the 
hospital compared to those that spent less than a week in hospital admission. Long hospital 
stay increases children’s chances of catching hospital acquired infections (76) bringing severe 
complications and deaths in children with severe malaria. Severe malaria already poses 
bacterial infection risk in children. Hospital acquired infections are one of the leading cause 
of death in hospitalized patients and have a vicious cycle. The hospital acquired infections 
prolong hospital stay and prolonged hospital stay predisposes hospitalized patients to more 
hospital acquired infections creating a vicious cycle. These infections are difficult to treat due 
to resistances and have high case fatality rates  (77). In this study most of the children were 
treated with antibiotics, 13 out of the 15 children who died were treated with antibiotics 
covering for bacterial infections which would be hospital-acquired. However, review by Jane 
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Crawley and colleagues noted that antibiotics treatment in children with severe malaria has 
less impact on reducing the current death rates for severe malaria children with other life 
threatening infections (78). 
4.2.3 Unconscious state 
State of unconsciousness on admission had high odds of dying. Children who were 
unconscious were 16 times more likely to die compared to those who were fully conscious on 
admission. There was a case fatality rate of 50% among children who presented on admission 
with unconscious state.  Unconsciousness is one of the danger sign in sick children and may 
result from failure of multiple organs or physiological systems. Unconscious patients may 
have a collapsed airway, low blood sugars or electrolyte imbalances or brain damage making 
them critically sick. They may therefore, require resuscitation and intensive care services 
which are lacking at the health centres and district hospital in Malawi. This increases the 
chances of dying in children with severe malaria.  Previous studies have reported 
unconsciousness (prostration or coma), convulsions, respiratory distress, severe anaemia as 
important clinical features related to outcomes of severe malaria in children (45,46,52,79). 
Therefore children with severe malaria presenting with unconsciousness must be given 
priority and maximum clinical care to ensure survival. Health system needs to be well 
equipped or resourced and coordinated to provide for proper care of unconscious children 
with severe malaria.  
 
4.2.4 Treatment with Lumefantrine and Artemether (LA) 
The study found that those children that were treated with LA were less likely to die in 
hospital. LA is treatment for uncomplicated malaria according to the Malawi National 
Malaria Control Program Treatment guidelines. In this study LA was given to children that 
had already improved and were out of clinical danger. It is therefore not surprising that use of 
LA predicated low chances of dying in children with severe malaria. However, this is 
encouraging as it implies effectiveness of treatment malaria in children that were given LA 
and it needs to be encouraged. 
4.3 STUDY LIMITATIONS 
Missing and incomplete medical records were a major short coming of this study. There were 
inconsistencies in the data being collected by different clinicians in the absence of standard 
prescribed admission forms and discharge notes. Factors such conscious levels, vital signs, 
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laboratory test results for classification and confirmation of other diagnoses other than 
malaria, socioeconomic and demographic data on the parent or guardian of the child were 
difficult to find or completely unavailable. The study was restricted only on hospital collected 
data, missing outcomes beyond the hospital for those that were referred and those that 
absconded resuting in small numbers of cases studied limiting the multivariate analysis.  The 
study could not look into other predictors of outcomes of severe malaria associated with the 
home environment.  
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5.  CONCLUSIONS AND RECOMMENDATIONS 
Admission of children with severe malaria in Mchinji district suggests that there is still need 
to improve access to early diagnosis and treatment of malaria in the district. There is need to 
maintaining a high index of suspicion for severe malaria at all level. The intervention to 
prevent malaria related mortality remains early detection, treatment and referral where 
necessary to minimize complications and deaths. Delays in accessing proper treatment for 
uncomplicated malaria cases, incorrect diagnosis or treating children with ineffective 
treatments need to be minimized. This study demonstrated that the outcomes of children with 
severe malaria are not only related to clinical characteristics of the patients. They are also 
related to health system factors like, being referred from a primary health facility, long stay in 
hospital  and being treated with LA during the course of treatment. These factors influence 
severity of complications in children with severe malaria. Therefore, the health system needs 
to be appropriately resourced to take care of severe malaria cases. There is need to investigate 
and address gaps in access and provision of prompt malaria treatment at community and 
health facility levels to minimise delays in management of children with malaria, specifically 
in the referral system and health seeking behaviour among the communities of Mchinji 
district.  
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APPENDIX 1 
▪ PLAGIARISM DECLARATION REPORT 
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APPENDIX 2 
▪ HUMAN RESEARCH ETHICS CLEARANCE CERTIFICATE 
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APPENDIX 4 
▪ DATA COLLECTION FORM 
 
PREDICTORS OF OUTCOMES FOR SEVERE CHILDHOOD MALARIA CASES 
ADMITTED AT MCHINJI DISTRICT HOSPITAL IN MALAWI 
Data Extraction Sheet (fill in accordingly) 
Name of Data 
Collector 
 Date of  data collection 
Date of admission 
Date of Discharge 
Patient Demographics 
Identity  
Village/ Town Age Gender Weight MUAC Brought by 
       
Referred from   
Home School Health Centre 
Rural 
Hospital 
Other 
 ( Specify) 
  
       
Reason for referral   
 
Date, Day of the week and  time 
Admission       
Discharge       
Duration of 
admission 
 
Outcome of admission 
Alive Dead Unknown Other 
Presenting Complaint and duration on admission   
Fever Convulsions Unconsciousness Vomiting Not eating 
Unable to 
sit 
Shortness 
of breath 
Cough 
Not passing 
urine 
Other     
Physical Examination   
Temperature PR RR BP 
Comma Scale/ 
Dehydration 
Spontaneou
s Bleeding 
Splenomegaly 
Parasitae
mia 
Haemoglob
in 
Blood sugar       
Diarrhoea Vomiting      
Diagnosis 
on 
admission 
 
Other Diagnosis (chronic heart disease, HIV disease, malnutrition, diabetes, etc   
 
Treatment given   
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APPENDIX 5  
▪ WHO CRITERIA FOR SEVERE MALARIA 
 
One or more of the following clinical or laboratory features 
Clinical Manifestations  
▪ Prostration 
▪ Impaired consciousness 
▪ Respiratory distress (acidotic breathing) 
▪ Multiple convulsions 
▪ Circulatory collapse 
▪ Pulmonary edema (radiological) 
▪ Abnormal bleeding 
▪ Jaundice 
▪ Hemoglobinuria 
Laboratory Test  
▪ Severe anemia 
▪ Hypoglycemia 
▪ Acidosis 
▪ Renal impairment 
▪ Hyperlactatemia 
▪ Hyperparasitemia 
 
Taken from WHO Guidelines for the Treatment of Malaria. (WHO, Geneva Switzerland: 
2006).  
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APPENDIX 6  
▪ WHO GUIDELINES FOR THE TREATMENT OF SEVERE MALARIA 
 
Summary of recommendations on the treatment of severe malaria 
Severe malaria is a medical emergency. After rapid clinical assessment and confirmation of 
the diagnosis, full doses of parenteral antimalarial treatment should be started without delay 
with whichever effective antimalarial is first available. 
Artesunate 2.4 mg/kg body weight (bw) i.v. or i.m. given on admission (time 3 0), then at 12 
h and 24 h, then once a day is the recommended choice in low-transmission areas or 
outside malaria-endemic areas. 
For children in high-transmission areas, the following antimalarial medicines are 
recommended as there is insufficient evidence to recommend any of these antimalarial 
medicines over another for severe malaria:  
▪ Artesunate 2.4 mg/kg bw i.v. or i.m. given on admission (time 3 0), then at 12 h and 24 h, 
then once a day; 
▪ Artemether 3.2 mg/kg bw i.m. given on admission then 1.6 mg/kg bw per day; 
▪ Quinine 20 mg salt/kg bw on admission (i.v. infusion or divided i.m. injection), then 10 
mg/kg bw every 8 h; infusion rate should not exceed 5 mg salt/kg bw per hour. 
▪ Artesunate or artemisinin by rectal administration 
▪ Artesunate or artemether i.m. 
▪ Quinine i.m. 
Use the parenteral antimalarial treatment locally available for severe malaria in full doses. 
Where available, AS is the first and artemether the second option in the second and third 
trimesters. In the first trimester, until more evidence becomes available, both artesunate and 
quinine may be considered as options. 
 
Levels of evidence:  
S - Formal systematic reviews, such as a Cochrane Review, including more than one 
randomized controlled trial;  
T - Comparative trials without formal systematic review;  
O - Observational studies (e.g., surveillance or pharmacological data);  
E -  Expert opinion/consensus. 
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